Spuriously low or high automated WBC counts seen in laboratory practice can cause diagnostic and therapeutic dilemma. WBC histograms and scatterplots may have clues to the presence of an abnormal WBC population or interfering substances [1, 2] . We present a series of 14 patients in whom the automated WBC count was spuriously elevated due to interference by fibrin clumps. These patients were undergoing treatment for various hematological disorders (9 patients were chemotherapy and 5 patients were post bone marrow transplant).
Complete blood count (CBC) was done on BC 3000 plus (Mindray) three-part automated hematology analyzer. In 12 of the 14 patients, daily or alternate day counts were being monitored due to low WBC count. In 10 of the 14 patients, the WBC count reported initially was much higher than the expected rise over 24 h. In four patients, presence of fibrin clumps was suspected on viewing the abnormal WBC histogram pattern. Repeat samples were requested in all 14 patients which showed lower WBC counts compared to initial samples. The initial WBC counts were 2.2-40 times higher than the actual value. Hemoglobin, RBC indices and platelet counts were similar in both samples (Table 1) . Peripheral blood smears in all patients showed fibrin clumps at the tail end of the smears (Fig. 1a, b) . The manual WBC count estimated from the peripheral smear conformed to that seen on repeat automated CBC estimation.
The histograms in all patients were abnormal with a straight ascending limb as compared to a rising sloping pattern seen in normal WBC histograms. The straight limb was not seen in the repeat samples. The height of the WBC histogram peak on the Y-axis was also lower in the repeat samples. The descending limb was normal in patients with fibrin clumps (Fig. 1) . To study the specificity of the WBC histogram abnormality, we analyzed 1008 consecutive WBC histograms in patients who had simultaneous peripheral smear examination. None of the cases showed the abnormal histogram pattern.
Spuriously high WBC counts can be caused by platelet aggregates, giant platelets, nucleated red blood cells, RBCs with lytic resistance, cryoglobulins, adipose tissue fragments, fibrin clumps and micro-organisms [2] [3] [4] . Fibrin clumps is an uncommon cause of spuriously high WBC count and can cause false elevation of WBC counts. We report a previously undescribed abnormality in the WBC histogram due to interference by fibrin clumps. Nine of the patients in our study were in high dependency settings with central lines in place for drug delivery and sampling. Prolonged use of central lines results in localized fibrin precipitates in and around the line ports. While drawing a blood sample, fibrin may be introduced in the sample and can cause interference in automated counts. Slow sample draws and difficult venipuncture may also introduce these in blood samples [5] . Tiny fibrin clumps resulting in spurious WBC counts may be undetected at times. Careful blood smear examination with emphasis to the tail end is also helpful in detecting this artefact. The size and number of fibrin strands being variable in different blood samples, no prediction can be made regarding the degree of WBC rise that may be seen. Since WBC differential scatterplots or histograms may show abnormalities in the presence of fibrin clumps, technical staff and pathologists must be trained to identify them, and request repeat samples to avoid erroneous results that may lead to inappropriate management [1, 2] .
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